Sign up by using the form below and stay up to date with the latest developments in the European pharmaceutical and life sciences industry.
If you want to change your preferences just fill in this form again using the same email address or click the update preferences or unsubscribe links in any of the emails we send.
Latest content
- Lilly announces new study data on Inluriyo in metastatic breast cancer
- Galderma’s Nemluvio rapidly relieves atopic dermatitis and prurigo nodularis symptoms
- PMLiVE’s T40 2025 – results announced!
- Nektar Therapeutics announces top-line results from alopecia areata study
- Havas Life London unveils AI awareness campaign




